These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 34678603)
1. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors. Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603 [TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. Bekircan O; Danış Ö; Şahin ME; Çetin M Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors. Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors. Çeçen M; Oh JM; Özdemir Z; Büyüktuncel SE; Uysal M; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Mathew B; Kim H Molecules; 2020 Nov; 25(22):. PubMed ID: 33212876 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors. Kumar B; Sheetal ; Mantha AK; Kumar V Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors. Sağlık BN; Cebeci O; Acar Çevik U; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA Molecules; 2020 Sep; 25(18):. PubMed ID: 32971892 [TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors. Ilgın S; Osmaniye D; Levent S; Sağlık BN; Acar Çevik U; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA Molecules; 2017 Dec; 22(12):. PubMed ID: 29232838 [TBL] [Abstract][Full Text] [Related]
8. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library. Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues. Evranos-Aksoz B; Ucar G; Yelekci K Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition. El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE Bioorg Chem; 2024 Feb; 143():107011. PubMed ID: 38061181 [TBL] [Abstract][Full Text] [Related]
11. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B. Takao K; Saito T; Chikuda D; Sugita Y Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503 [TBL] [Abstract][Full Text] [Related]
12. Biphenylpiperazine Based MAO Inhibitors: Synthesis, Biological Evaluation, Reversibility and Molecular Modeling Studies. El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE Bioorg Chem; 2021 Oct; 115():105216. PubMed ID: 34352710 [TBL] [Abstract][Full Text] [Related]
13. In Silico Design, Synthesis of Hybrid Combinations: Quercetin Based MAO Inhibitors with Antioxidant Potential. Dhiman P; Malik N; Khatkar A Curr Top Med Chem; 2019; 19(2):156-170. PubMed ID: 30747068 [TBL] [Abstract][Full Text] [Related]
14. Novel thiazolyl-hydrazone derivatives including piperazine ring: synthesis, Osmaniye D; Alaşan R; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA Z Naturforsch C J Biosci; 2022 Mar; 77(3-4):167-175. PubMed ID: 34674410 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies. Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657 [TBL] [Abstract][Full Text] [Related]
16. Exploration of Umbelliferone Based Derivatives as Potent MAO Inhibitors: Dry vs. Wet Lab Evaluation. Dhiman P; Malik N; Khatkar A Curr Top Med Chem; 2018; 18(21):1857-1871. PubMed ID: 30430943 [TBL] [Abstract][Full Text] [Related]
17. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains. Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816 [TBL] [Abstract][Full Text] [Related]